Objective: The peroneal artery is a well-established target for bypass in patients with critical limb ischemia (CLI). The objective of this study was to evaluate the outcomes of peroneal artery revascularization in terms of wound healing and limb salvage in patients with CLI.
Critical limb ischemia (CLI) leads to high rates of major amputation and mortality rates as high as 40% at 2 years. 1, 2 Patients with tibial artery disease have a higher risk of amputation compared with those with isolated femoropopliteal disease. 3 Tibial disease is commonly associated with chronic debilitating comorbidities, including diabetes mellitus, coronary artery disease, and chronic kidney disease (CKD), and end-stage renal disease, which place these patients at high risk of perioperative morbidity and mortality. 4, 5 Historically, distal bypass was the main treatment to avoid limb loss from CLI, but endovascular interventions for infrapopliteal disease have been shown to be similar to distal bypass in limb salvage and amputation-free survival, with fewer perioperative complications. 6 Although distal bypasses to peroneal artery have good results, 7, 8 there is less evidence that endovascular interventions on an isolated peroneal runoff are effective. We have previously found at our institution that among all patients undergoing endovascular tibial intervention, those with isolated peroneal runoff had poorer rates of wound healing, 9 potentially questioning the efficacy of peroneal endovascular intervention compared with peroneal bypass. The objectives of this study were to evaluate the outcomes after revascularization of an isolated peroneal artery runoff and to compare peroneal bypass with endovascular peroneal intervention in patients undergoing lower extremity revascularization for CLI. We specifically sought to determine whether the two treatment modalities were associated with similar rates of wound healing, limb salvage, and patency rates.
METHODS
This study was approved by the Institutional Review Board at the University of Pittsburgh; because of the retrospective nature of the study, the need for informed consent was waived. We performed a chart review of all consecutive patients presenting to the University of Pittsburgh Medical Center between 2006 and 2013 with CLI (Rutherford stage 4-6) and tibial occlusive disease who underwent revascularization of an isolated peroneal artery by either surgical bypass or endovascular intervention. Bypasses to the tibioperoneal trunk were included if the peroneal artery was the only runoff. Patients were excluded if the anterior or posterior tibial artery was successfully recanalized by endovascular intervention in the same setting. Thus, our cohort consisted of all patients in whom the peroneal artery was the sole runoff after revascularization. Patients treated for more proximal disease (by either endovascular intervention or bypass) in the same procedure were included. Patients were excluded if the procedure was not conducted at our institution or an operative report was not available.
The patients' demographics, past medical history (diabetes mellitus, CKD, hypertension, hyperlipidemia, coronary artery disease, coronary artery bypass graft, congestive heart failure, history of myocardial infarction, connective tissue disorder, chronic obstructive pulmonary disease, cancer, cerebrovascular disease, lower extremity neuropathy, and history of smoking), and prior medications were recorded. Wounds were classified on the basis of Wound, Ischemia, foot Infection (WIfI) criteria, which have been validated for use in infrapopliteal lesions. 10, 11 Anatomic lesions were characterized by conventional angiography in all patients, and the runoff score, which estimates the runoff resistance and helps to predict infrainguinal revascularization outcomes, was used to quantify the pedal disease burden. 12 Although runoff scores are designed for determination of bypass outflow resistance, a runoff score was also calculated for the endovascular group as if a peroneal bypass were performed to provide an objective comparison of distal runoff. The runoff score for a peroneal artery bypass is calculated by scoring the degree of occlusion in the pedal arch and the collaterals from the peroneal artery to the anterior and posterior tibial arteries on a scale of 0 to 3 (with 3 indicating complete occlusion) and combining these scores into a scale of 1 to 10 (by double-weighting the pedal arch score, singleweighting the collateral score, and adding 1 point). 13 Details of the intervention, complications of the initial treatment, subsequent interventions, amputations, primary patency, primary assisted patency, secondary patency, mortality, and wound healing were all reviewed.
The primary end point was successful wound healing, defined as the first time point of complete wound healing as documented either in outpatient or subsequent hospitalization records. The vascular surgeon coordinated wound care in all patients. Wounds were evaluated in the office on a biweekly basis to optimize the wound care strategy. Dressing changes and other aspects of wound care may have been provided by the patient or family members, visiting nurses, or staff at a skilled nursing facility as appropriate for each patient's individual needs. The secondary end points were primary, primary assisted, and secondary patency rates; major amputation (above the ankle level); and death. The subset of patients without tissue loss were excluded for study of wound healing but included in all other analyses.
Excel (Microsoft, Redmond, Wash) was used to compile data. Stata/SE 13.0 software (StataCorp LP, College Station, Tex) was used to conduct statistical analyses, under the guidance of a statistician. Categorical data were compared using the c 2 test, and continuous data were compared with Student t-test. Thirty-day outcomes were analyzed by logistic regression. Kaplan-Meier and cumulative incidence analyses were used to calculate time-dependent patency rates, amputation-free survival, wound healing, and survival, and the log-rank test was used for comparisons between groups. All predictors with P < .20 in the univariate analysis were included in a backward stepwise elimination to create a multivariate Cox regression model. A P value of .05 was considered significant for all statistical tests, and standard error was <10% in all depicted Kaplan-Meier curves.
RESULTS
From 450 limbs that had endovascular intervention or bypasses to the peroneal artery or the tibioperoneal trunk, 112 were excluded because the peroneal artery was not the only runoff. Of the remaining 338 limbs, 200 underwent bypass and 138 underwent endovascular intervention. There were 44 bypass patients (22.0%) and
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13 endovascular patients (9.4%) with rest pain but no wounds. Mean follow-up was 24.0 6 26.3 months and 14.5 6 19.1 months, respectively (P ¼ .0001).
Baseline characteristics were mostly similar. Patients who underwent endovascular intervention were more likely to have diabetes mellitus (P ¼ .03), CKD (P < .001), end-stage renal disease (P ¼ .001), and history of myocardial infarction (P ¼ .005) but less likely to have a smoking history (P < .001). They were more likely to be receiving dual antiplatelet therapy (P ¼ .049) but less likely to be receiving statin therapy (P ¼ .01). Preoperative anklebrachial index (ABI) was lower in the bypass group. When wounds were scored by the WIfI criteria, the wound and foot infection scores were worse in the endovascular group, whereas the ischemia scores were worse in the bypass group. Pedal runoff scores were nearly identical between the two groups (Table I) .
Among patients who underwent bypass, the inflow was suprageniculate in 92.0% and infrageniculate in 8.0%. The target artery was the peroneal artery in 92.5% and the tibioperoneal trunk in 7.5%. Great saphenous vein was used in 70.5%, with the remainder requiring alternative autologous vein (23.5%) or prosthetic conduit (6.0%). Thirty-eight patients (19.0%) underwent a concomitant procedure to improve the inflow, by either endovascular or open intervention. Among patients who underwent endovascular intervention, the peroneal artery was the only treated tibial artery in 75.4%; in the remainder of patients, an attempted recanalization of the anterior or posterior tibial arteries was unsuccessful. In the peroneal artery, balloon angioplasty was performed in all cases, along with atherectomy in 5.8% and adjunctive stenting in 6.5%. An iatrogenic dissection of the target artery after balloon angioplasty was found in 14 cases (10.1%) and was treated by observation in 8 cases, stenting in 3 cases, and prolonged inflation in 3 cases. Ninety-four patients (68.1%) underwent concomitant femoropopliteal or iliac intervention. One patient underwent a common femoral artery to belowknee popliteal artery bypass and peroneal artery balloon angioplasty in the same setting (a femoroperoneal bypass was not performed because of conduit limitations). The remainder received endovascular intervention.
Postoperative outcomes are summarized in Table II . Hospital stay was longer after bypass surgery than after endovascular intervention (7.26 days vs 4.80 days; P < .001). At 30 days, patients who underwent a bypass had higher rates of myocardial infarction (4.5% vs 0.0%; P ¼ .01) and surgical site complications (13.0% vs 4.4%; P ¼ .008) and reoperations for surgical site complications (7.0% vs 0.0%; P ¼ .001). There was no difference between groups in 30-day major adverse limb event or major adverse cardiovascular event rates. The overall number of reinterventions was similar in both groups. Postoperative ABI was higher in the bypass group, and patients were more likely to have improvement in their ABI after bypass compared with endovascular intervention (40.5% vs 28.3%; P < .001). Overall 30-day mortality and major amputation were 4.4% and 5.0%, respectively, with no difference between groups (P ¼ .64 and P ¼ .21, respectively).
At 12 months, primary patency was better in the bypass group (47.9% vs 23.4%; P ¼ .002), as was primary assisted patency (63.6% vs 42.2%; P ¼ .004; Fig 1, A and B ). There was a trend toward better secondary patency in the bypass group (74.2% vs 63.5%; P ¼ .12; Fig 1, C) . During the follow-up period, the mean number of reinterventions was similar between groups (0.62 vs 0.72; P ¼ .43). Fifteen patients (10.9%) who had originally undergone endovascular peroneal intervention underwent a subsequent peroneal bypass, and 11 patients (5.5%) who had originally undergone peroneal bypass underwent a subsequent endovascular peroneal intervention.
There was no difference between the bypass and endovascular groups with respect to either wound healing (in the 281 patients with wounds; P ¼ .09) or major amputation (P ¼ 0001; Fig 4) . At 4 years, survival was 27.5% in the bypass group and 14.5% in the endovascular group.
DISCUSSION
In this study, we sought to describe the patency and limb-related outcomes in patients undergoing revascularization of an isolated peroneal runoff and to determine whether patients undergoing endovascular intervention had outcomes similar to those of patients undergoing surgical bypass. We performed a retrospective chart review of such patients at our institution to compare these two groups of patients.
In the infrapopliteal arteries, surgical bypass continues to be the standard against which any novel therapy is compared. Patients with CLI often have a number of medical comorbidities that place them at higher risk of perioperative complications and long-term mortality. 3, 14 Endovascular tibial intervention provides an attractive alternative in part because it provides improved perioperative outcomes. Indeed, in our study, we found that patients undergoing endovascular peroneal intervention had shorter lengths of stay and fewer cardiac and surgical site complications without any increase in adverse limb outcomes compared with those undergoing peroneal bypass. In patients who are believed to be poor surgical candidates, our results showed that 30-day outcomes were favorable after endovascular intervention.
In follow-up of our cohort, we found that bypass was associated with improved patency compared with endovascular intervention. This difference was most notable in primary patency rates, which were approximately twice as high in the bypass group. The difference was less impressive and no longer statistically significant in comparing secondary patency rates, which suggests that reinterventions are more critical to the success of an endovascular treatment strategy. Our patency findings imply that reintervention rates may be higher in the endovascular patients; however, we noted no difference in the mean number of reinterventions between the two groups. We suspect this is the case for two reasons. First, follow-up was shorter in the endovascular group, and a longer follow-up period may have shown more reinterventions in patients who received endovascular intervention. Second, we have differing strategies with regard to reinterventions in these two groups of patients. In patients with a bypass, reinterventions are performed for any >50% stenosis on surveillance duplex ultrasound studies to prevent graft thrombosis regardless of whether clinical end points (such as wound healing or resolution of rest pain) are achieved. In patients with an endovascular intervention, a restenosis or occlusion is generally not treated unless clinical symptoms recur or fail to improve.
Despite the differences in patency rates between the two treatment modalities, we observed no difference in long-term limb-related outcomes in our cohort. The rates of wound healing and major amputation were similar between groups. Our Kaplan-Meier estimated wound healing rates were somewhat low in both groups; in addition to severe arterial insufficiency, the population of patients studied had high rates of diabetes and renal dysfunction, both known to impair wound healing. Furthermore, poor nutritional status is likely to be common in this population but was difficult to assess retrospectively. We did note a higher long-term mortality rate in the patients who underwent endovascular intervention, without any associated increase in 30-day mortality. We suspect this is a result of selection bias, in that patients who were believed to be good candidates for a distal bypass operation were likely to be at decreased risk of all-cause mortality. This is supported by the higher rates of medical comorbidities in the endovascular group. The peroneal artery is unique in that it is often relatively spared of atherosclerotic disease compared with the anterior and posterior tibial arteries but terminates at the ankle and perfuses the foot indirectly through collateral branches; in light of the traditional mantra that in-line flow must be achieved to heal wounds, the anatomy of the peroneal artery calls into question whether it would be an appropriate bypass target in patients with CLI. Darling et al 8 previously studied bypasses to the peroneal artery compared with those to a dorsalis pedis artery, finding a 76% secondary patency and 93% limb salvage rate at 5 years; the authors concluded that the peroneal artery was a good alternative to a pedal target in the presence of conduit limitations or foot infection close to the pedal target. No studies to date have specifically described the patency rates of peroneal artery endovascular interventions in a cohort of patients with an isolated peroneal artery runoff. Two studies, however, have compared the outcomes after infrainguinal intervention in patients with peroneal artery-only runoff with those with other runoff. 15, 16 A large fraction of patients in both studies underwent isolated femoropopliteal interventions, and thus their patency rates cannot be compared with ours; however, both groups of investigators concluded that isolated peroneal runoff by itself does not negatively affect outcomes after revascularization. Similar to these previous studies, we found overall acceptable patency and limb salvage rates with any form of peroneal artery revascularization, further supporting the use of the peroneal artery as a bypass or endovascular intervention target despite its lack of direct perfusion to the foot. There are a number of limitations to this retrospective study. Most notably, selection bias plays a role in the treatment modality that patients are offered. Patients who underwent endovascular intervention had higher rates of many medical comorbidities and are inherently different from patients who were offered a surgical bypass. Specifically, the endovascular group had higher rates of diabetes and renal impairment than the bypass group; both of these risk factors are well known to be associated with calcified lesions in the infrapopliteal segment. 3 We did account for this to the extent possible with the use of multivariate regression modeling techniques but cannot account for other unknown or unmeasured confounders that distinguish the two groups. High rates of disease recurrence after balloon angioplasty in calcified lesions may explain the inferior patency of endovascular intervention in this arena. Conduit limitations may have affected the treatment decision, as most surgeons would favor endovascular intervention more strongly in patients without adequate vein. Bias between surgeons with regard to indications is also possible and may affect outcomes of the two therapies, but the collaborative nature of our practice probably limits this effect. In addition, we were unable to study more granular characteristics of wounds, such as their size, location on the foot, or intensity or quality of wound care, which may have an impact on their healing. Likewise, more granular arterial lesion characteristics, such as length or degree of calcification, were not available for review. Furthermore, high rates of both mortality and loss to follow-up decreased the number of patients in whom accurate wound healing documentation could be acquired. Prospective, randomized studies in this area, such as the Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial, 17 would benefit from comparison groups with more similar baseline risk factors and improved documentation and characterization of wound location and severity. However, the immense heterogeneity in clinical and anatomic disease patterns poses a significant challenge to completion of these studies and interpretation of their results, and thus surgeons must often rely on retrospective work to address such clinical questions. Based on our observational findings, endovascular peroneal interventions seem to allow fewer perioperative complications and similar wound healing and limb salvage rates compared with bypass surgery, at the cost of less durable patency rates. 
CONCLUSIONS
Endovascular peroneal artery intervention results in lower primary and primary assisted patency rates compared with surgical bypass to the peroneal artery but may offer similar rates of wound healing and limb salvage in short-term follow-up. In appropriately selected patients, endovascular intervention to treat the peroneal artery is a low-risk intervention that may be sufficient to heal ischemic foot wounds. 
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